Status: question. Rule: atlas-profile-2.0.
4 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: STRONG (retained from 22 September 2026; not a completed profile 2.0 assessment).
Deployment and trust depend entirely on external performance; if most claims collapse on transfer, the field's evidentiary base is weaker than it appears. Note the STRONG evidence for this failure mode comes from adjacent medical-imaging AI; the glioma-specific meta-review has not been done.
Internal AUCs are high; systematic reviews of medical-imaging AI (e.g. an emergency head-CT CNN meta-review [Menp2024]) find external validation rare and TRIPOD reporting adherence poor, and no equivalently rigorous glioma-imaging external-validation meta-review yet exists — the gap this question targets.
Meta-research: systematic re-validation of top-cited models on held-out multi-institutional data with standardized reporting (CLAIM/TRIPOD-AI); publish the generalization-gap distribution.
This question comes from selected literature. Confirm that the gap remains open with a current search and mentor review.
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.